Literature DB >> 20567840

HTLV infection and its implication in gynaecology and obstetrics.

Ioannis Mylonas1, Ansgar Brüning, Franz Kainer, Klaus Friese.   

Abstract

INTRODUCTION: Worldwide, 20-30 million people are estimated to be infected with HTLV. HTLV-1 is endemic in Western Africa and Southern Japan, whereas HTLV-2 is considered to be spread among native American people.
MATERIALS AND METHODS: The impact of HTLV in gynaecology and obstetrics is being reviewed. Search strategy and selection criteria for identifying relevant data were performed by searching Medline, Current Contents, Web of Science, Embase and references from relevant articles. English and German gynaecological and infectious diseases textbooks as well as national and international guidelines and recommendations were also reviewed.
RESULTS: Transmission may occur by sexual intercourse or cellular blood products. Although materno-fetal transmission is debated, transmission through maternal breast milk has been confirmed. An HTLV-infection can lead to adult T-cell leukaemia (ATL) or cumulative opportunistic and neurological disorders that can occur with varying degrees of severity. Diagnosis can be done by antibody detection via the use of ELISA and western blot analysis as well as PCR diagnosis.
CONCLUSION: Due to inadequate treatment options and the lack of an effective vaccination, prevention is currently only possible by restricting transmission, including the usage of condoms during sexual intercourse or avoiding breastfeeding in HTLV-seropositive mothers. If, due to socio-economic reasons, breastfeeding cannot be avoided, short-term breastfeeding for a maximum of up to 6 months is suggested.

Entities:  

Mesh:

Year:  2010        PMID: 20567840     DOI: 10.1007/s00404-010-1559-1

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  6 in total

Review 1.  Human T-cell leukemia virus-associated malignancy.

Authors:  Amanda R Panfil; Michael P Martinez; Lee Ratner; Patrick L Green
Journal:  Curr Opin Virol       Date:  2016-08-31       Impact factor: 7.090

2.  Stopping breastfeeding to prevent vertical transmission of HTLV-1 in resource-poor settings: beneficial or harmful?

Authors:  Carla van Tienen; Marianne Jakobsen; Maarten Schim van der Loeff
Journal:  Arch Gynecol Obstet       Date:  2012-01-07       Impact factor: 2.344

3.  Prevalence of human T-cell leukemia virus type 1 carrier in Japanese pregnant women in 2013.

Authors:  Shunji Suzuki; Masanobu Tanaka; Hideo Matsuda; Yuki Tsukahara; Yasushi Kuribayashi; Akihito Nakai; Ryoichiro Miyazaki; Naoki Kamiya; Akihiko Sekizawa; Nobuko Mizutani; Katsuyuki Kinoshita
Journal:  J Clin Med Res       Date:  2015-04-08

4.  Human T-lymphotropic virus 1 and 2 among people who used illicit drugs in the state of Pará, northern Brazil.

Authors:  Aldemir B Oliveira-Filho; Ana Paula S Araújo; Andreia Polliana C Souza; Camila M Gomes; Gláucia C Silva-Oliveira; Luísa C Martins; Benedikt Fischer; Luiz Fernando A Machado; Antonio Carlos R Vallinoto; Ricardo Ishak; José Alexandre R Lemos; Emil Kupek
Journal:  Sci Rep       Date:  2019-10-14       Impact factor: 4.379

5.  Human T-Lymphotropic Virus type 1 infection in an Indigenous Australian population: epidemiological insights from a hospital-based cohort study.

Authors:  Lloyd Einsiedel; Richard J Woodman; Maria Flynn; Kim Wilson; Olivier Cassar; Antoine Gessain
Journal:  BMC Public Health       Date:  2016-08-15       Impact factor: 3.295

Review 6.  Human T-Cell Leukemia Virus Type 1 Envelope Protein: Post-Entry Roles in Viral Pathogenesis.

Authors:  Victoria Maksimova; Amanda R Panfil
Journal:  Viruses       Date:  2022-01-13       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.